Nan Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 23
- RNA modifications and cancer 9
- RNA Research and Splicing 8
- RNA Interference and Gene Delivery 5
-
- Cancer-related molecular mechanisms research 25
- MicroRNA in disease regulation 23
- Co-authors
- Ning Ji (1 shared paper)Zhiyong Ding (1 shared paper)Zhe‐Sheng Chen (1 shared paper)Youyi Xiong (13 shared papers)Yuanting Gu (12 shared papers)Guohui Yang (4 shared papers)Lin Li (6 shared papers)Zubin Zhou (7 shared papers)
- Journals
- Frontiers in Oncology (4 papers)OncoTargets and Therapy (4 papers)Frontiers in Immunology (3 papers)Cancer Cell International (3 papers)Journal of Inflammation Research (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Nan Wang
143 papers receiving 2.2k citations
Nan Wang's Hit Papers
Peers
Comparison fields: 5 of 132
- Cancer Research 686
- Molecular Biology 967
- Hepatology 67
- Oncology 190
- Pulmonary and Respiratory Medicine 212
Countries citing papers authored by Nan Wang
This map shows the geographic impact of Nan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Wang more than expected).
Fields of papers citing papers by Nan Wang
This network shows the impact of papers produced by Nan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Wang. The network helps show where Nan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Nan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Proteomics technologies for cancer liquid biopsies Hit paper breakdown → | 2022 | 163 |
| 2 | 2014 | 90 | |
| 3 | 2016 | 65 | |
| 4 | 2012 | 61 | |
| 5 | 2004 | 53 | |
| 6 | 2015 | 50 | |
| 7 | 2021 | 49 | |
| 8 | 2020 | 45 | |
| 9 | 2021 | 39 | |
| 10 | 2021 | 37 | |
| 11 | 2019 | 36 | |
| 12 | 2018 | 34 | |
| 13 | 2021 | 34 | |
| 14 | 2024 | 34 | |
| 15 | 2019 | 34 | |
| 16 | 2021 | 34 | |
| 17 | 2021 | 33 | |
| 18 | 2018 | 33 | |
| 19 | 2021 | 33 | |
| 20 | 2011 | 32 |
About Nan Wang
Nan Wang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology, having authored 154 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (23 papers), Circular RNAs in diseases (23 papers), RNA modifications and cancer (9 papers), RNA Research and Splicing (8 papers), Ferroptosis and cancer prognosis (6 papers), RNA Interference and Gene Delivery (5 papers) and Rock Mechanics and Modeling (5 papers). The work is most often cited by research in Cancer Research (686 citations), Molecular Biology (967 citations), Hepatology (67 citations), Oncology (190 citations) and Pulmonary and Respiratory Medicine (212 citations). Nan Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ning Ji, Zhiyong Ding, Zhe‐Sheng Chen, Youyi Xiong, Yuanting Gu, Guohui Yang, Lin Li, Zubin Zhou, Yong Luan and Hua Meng. Their work appears in journals such as Frontiers in Oncology, OncoTargets and Therapy, Frontiers in Immunology, Cancer Cell International and Journal of Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.